Demant A/S

Copenhagen Stock Exchange DEMANT.CO

Demant A/S EBIT for the year ending December 31, 2023: USD 574.91 M

Demant A/S EBIT is USD 574.91 M for the year ending December 31, 2023, a 33.54% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Demant A/S EBIT for the year ending December 31, 2022 was USD 430.50 M, a -18.36% change year over year.
  • Demant A/S EBIT for the year ending December 31, 2021 was USD 527.30 M, a 130.60% change year over year.
  • Demant A/S EBIT for the year ending December 31, 2020 was USD 228.66 M, a -21.91% change year over year.
  • Demant A/S EBIT for the year ending December 31, 2019 was USD 292.81 M, a -18.25% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Loading...
Copenhagen Stock Exchange: DEMANT.CO

Demant A/S

CEO Mr. Søren Nielsen
IPO Date May 8, 2000
Location Denmark
Headquarters Kongebakken 9
Employees 21,501
Sector Health Care
Industries
Description

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Similar companies

ROCK-B.CO

Rockwool A/S

USD 337.09

1.17%

ISS.CO

ISS A/S

USD 17.79

-0.41%

AMBU-B.CO

Ambu A/S

USD 18.73

1.26%

GN.CO

GN Store Nord A/S

USD 17.06

1.00%

COLO-B.CO

Coloplast A/S

USD 109.06

-0.12%

StockViz Staff

January 15, 2025

Any question? Send us an email